Header Logo

Gary Chmielewski

Concepts (173)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
11
2019
247
1.100
Why?
Biomarkers, Tumor
4
2014
101
0.380
Why?
Thoracotomy
2
2010
9
0.380
Why?
Thoracic Surgery, Video-Assisted
2
2009
7
0.350
Why?
Pneumonectomy
2
2009
34
0.340
Why?
Adenocarcinoma
5
2015
61
0.330
Why?
Carcinoma, Non-Small-Cell Lung
4
2014
106
0.310
Why?
Barrett Esophagus
3
2015
10
0.310
Why?
Catheter Ablation
3
2015
21
0.310
Why?
Intraoperative Complications
1
2009
29
0.290
Why?
Aged
13
2019
4000
0.240
Why?
Positron-Emission Tomography
1
2006
36
0.230
Why?
Female
16
2019
6974
0.220
Why?
Male
15
2019
6815
0.220
Why?
Pleurodesis
1
2003
1
0.190
Why?
Pleural Effusion, Malignant
1
2003
3
0.190
Why?
Drainage
1
2003
26
0.190
Why?
Echinocandins
2
2012
4
0.180
Why?
Neoplasm Staging
6
2019
168
0.170
Why?
Humans
17
2019
12240
0.170
Why?
Prognosis
4
2014
363
0.160
Why?
Treatment Outcome
7
2015
1478
0.150
Why?
Retrospective Studies
5
2014
1467
0.150
Why?
Middle Aged
10
2015
4043
0.150
Why?
Small Cell Lung Carcinoma
1
2019
6
0.150
Why?
Aged, 80 and over
7
2014
2152
0.150
Why?
False Positive Reactions
1
2019
23
0.150
Why?
Unnecessary Procedures
1
2019
16
0.140
Why?
Carcinoma, Squamous Cell
1
2019
70
0.140
Why?
Sensitivity and Specificity
2
2009
252
0.130
Why?
Mutagenicity Tests
1
2016
1
0.120
Why?
Teratogens
1
2016
1
0.120
Why?
Fetal Development
1
2016
2
0.120
Why?
Hazardous Substances
1
2016
2
0.120
Why?
Models, Animal
1
2016
74
0.120
Why?
Registries
3
2015
88
0.120
Why?
Cytokines
2
2014
107
0.120
Why?
Length of Stay
2
2009
126
0.120
Why?
Toxicity Tests
2
2012
4
0.110
Why?
Esophagoscopy
1
2015
8
0.110
Why?
Learning Curve
1
2015
7
0.110
Why?
Thoracoscopy
2
2019
12
0.110
Why?
Esophageal Neoplasms
1
2015
22
0.110
Why?
Insulin-Like Growth Factor Binding Proteins
1
2014
5
0.110
Why?
Neovascularization, Pathologic
1
2014
15
0.110
Why?
Insulin-Like Growth Factor II
1
2014
9
0.110
Why?
Clinical Competence
1
2015
96
0.100
Why?
Insulin-Like Growth Factor I
1
2014
36
0.100
Why?
Interleukin-2 Receptor alpha Subunit
1
2013
7
0.100
Why?
Solitary Pulmonary Nodule
1
2013
7
0.090
Why?
Multiple Pulmonary Nodules
1
2013
9
0.090
Why?
Fundoplication
1
2012
12
0.090
Why?
Radiosurgery
2
2010
17
0.090
Why?
Gastroesophageal Reflux
1
2012
17
0.090
Why?
Immunoassay
1
2012
18
0.090
Why?
Algorithms
3
2014
169
0.090
Why?
Embryonic Development
1
2012
3
0.090
Why?
Nitriles
1
2012
5
0.090
Why?
Embryo, Mammalian
1
2012
12
0.090
Why?
Neoplasm Recurrence, Local
1
2012
69
0.090
Why?
Pyrimidines
1
2012
16
0.090
Why?
Risk Assessment
2
2012
295
0.090
Why?
Triazoles
1
2012
14
0.090
Why?
Antifungal Agents
1
2012
15
0.090
Why?
Pyrazoles
1
2012
35
0.090
Why?
Fistula
1
2011
2
0.090
Why?
Gastric Fistula
1
2011
3
0.090
Why?
Esophagectomy
1
2011
14
0.090
Why?
Hospitals, Community
1
2011
7
0.080
Why?
Heart Diseases
1
2011
31
0.080
Why?
Community-Institutional Relations
1
2011
6
0.080
Why?
Medical Oncology
1
2011
23
0.080
Why?
Minority Groups
1
2011
40
0.080
Why?
Clinical Trials as Topic
1
2011
100
0.080
Why?
Prospective Studies
4
2015
817
0.080
Why?
Patient Selection
1
2011
111
0.080
Why?
Neoplasms
1
2011
94
0.080
Why?
Multivariate Analysis
3
2015
141
0.080
Why?
Survival Rate
2
2010
152
0.080
Why?
Probability
1
2009
45
0.070
Why?
Statistics, Nonparametric
1
2009
72
0.070
Why?
Thoracic Surgery
1
2009
13
0.070
Why?
Survival Analysis
1
2009
99
0.070
Why?
Kaplan-Meier Estimate
1
2009
85
0.070
Why?
Area Under Curve
3
2014
39
0.070
Why?
Recurrence
2
2014
126
0.070
Why?
Predictive Value of Tests
3
2014
218
0.070
Why?
Rats
3
2016
407
0.070
Why?
Laparoscopy
1
2009
95
0.070
Why?
Age Factors
1
2009
350
0.070
Why?
Animals
4
2016
2092
0.070
Why?
Minimally Invasive Surgical Procedures
1
2009
142
0.070
Why?
Tumor Burden
1
2007
14
0.060
Why?
Lung
2
2005
76
0.060
Why?
Cohort Studies
1
2009
827
0.060
Why?
Risk Factors
3
2015
1049
0.060
Why?
United States
3
2015
989
0.060
Why?
Adult
4
2014
3557
0.060
Why?
Pneumonia
2
2019
33
0.060
Why?
Protein-Lysine 6-Oxidase
1
2005
2
0.060
Why?
Carcinoma, Bronchogenic
1
2005
4
0.060
Why?
ROC Curve
2
2014
78
0.050
Why?
Catheters, Indwelling
1
2003
9
0.050
Why?
Proton Pump Inhibitors
2
2012
9
0.040
Why?
Rats, Inbred F344
2
2012
22
0.040
Why?
Time Factors
2
2015
695
0.040
Why?
Reoperation
2
2015
366
0.040
Why?
Tomography, X-Ray Computed
2
2014
281
0.040
Why?
Follow-Up Studies
2
2014
726
0.040
Why?
Postoperative Complications
2
2015
385
0.040
Why?
Young Adult
2
2014
863
0.040
Why?
Radiography
2
2013
258
0.040
Why?
Mediastinoscopy
1
2019
5
0.040
Why?
Bronchoscopy
1
2019
14
0.040
Why?
Early Detection of Cancer
1
2019
59
0.040
Why?
Abnormalities, Drug-Induced
1
2016
3
0.030
Why?
Rabbits
1
2016
110
0.030
Why?
Least-Squares Analysis
1
2015
5
0.030
Why?
Hospitals, Low-Volume
1
2015
3
0.030
Why?
Hospitals, High-Volume
1
2015
4
0.030
Why?
Remission Induction
1
2015
45
0.030
Why?
Linear Models
1
2015
115
0.030
Why?
Logistic Models
1
2015
196
0.030
Why?
Minnesota
1
2014
6
0.030
Why?
Illinois
1
2014
110
0.030
Why?
Disease Progression
1
2014
290
0.020
Why?
Reproducibility of Results
1
2014
324
0.020
Why?
Incidence
1
2014
338
0.020
Why?
Chemokine CCL3
1
2013
7
0.020
Why?
Granuloma
1
2013
11
0.020
Why?
Chemokine CXCL12
1
2013
8
0.020
Why?
Interleukin 1 Receptor Antagonist Protein
1
2013
9
0.020
Why?
Interleukin-10
1
2013
11
0.020
Why?
Respiratory Tract Infections
1
2013
12
0.020
Why?
Interleukin-6
1
2013
48
0.020
Why?
Decision Support Techniques
1
2012
24
0.020
Why?
Lymphatic Metastasis
1
2012
51
0.020
Why?
Tumor Necrosis Factor-alpha
1
2013
95
0.020
Why?
Maternal Exposure
1
2012
1
0.020
Why?
Voriconazole
1
2012
7
0.020
Why?
Injections, Subcutaneous
1
2012
12
0.020
Why?
Fetus
1
2012
20
0.020
Why?
Drug Combinations
1
2012
17
0.020
Why?
Tissue Distribution
1
2012
18
0.020
Why?
Cesarean Section
1
2012
20
0.020
Why?
Drug Evaluation, Preclinical
1
2012
18
0.020
Why?
Animals, Newborn
1
2012
29
0.020
Why?
Administration, Oral
1
2012
55
0.020
Why?
Feeding Behavior
1
2012
40
0.020
Why?
Body Weight
1
2012
72
0.020
Why?
Hematemesis
1
2011
2
0.020
Why?
Stomach Ulcer
1
2011
2
0.020
Why?
Dose-Response Relationship, Drug
1
2012
179
0.020
Why?
Esophageal Perforation
1
2011
7
0.020
Why?
Gastrointestinal Hemorrhage
1
2011
10
0.020
Why?
Fatal Outcome
1
2011
28
0.020
Why?
Pregnancy
1
2012
193
0.020
Why?
Bone and Bones
1
2012
83
0.020
Why?
Osteogenesis
1
2012
84
0.020
Why?
Research Design
1
2012
79
0.020
Why?
Candidiasis
1
2011
13
0.020
Why?
Sex Factors
1
2012
229
0.020
Why?
Michigan
1
2011
7
0.020
Why?
Sex Distribution
1
2011
34
0.020
Why?
Hospitalization
1
2012
158
0.020
Why?
Program Evaluation
1
2011
55
0.020
Why?
Healthcare Disparities
1
2011
34
0.020
Why?
Mice
1
2012
760
0.020
Why?
Radiotherapy Dosage
1
2007
42
0.020
Why?
Radiotherapy Planning, Computer-Assisted
1
2007
23
0.020
Why?
Aging
1
2012
680
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
68
0.010
Why?
RNA, Messenger
1
2005
157
0.010
Why?
Chmielewski's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (173)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_